Signify Premium Insight: Viz.ai, Hyperfine and Maximising Mobile MRI

Published: August 25, 2022

Viz.ai has been among the most successful medical imaging AI vendors over recent years. It was, for instance, among the earliest vendors to secure reimbursement for the use of its solution via the New Technology Add-on Payment (NTAP), it has been highly successful in funding rounds, laying claim to more than $250m, and has enjoyed a healthy succession of regulatory approvals. In meeting these milestones, Viz.ai has now found itself facing an ongoing difficulty; how best to get its solution into hospitals.

Already have an account? Sign in here